News, Resources, Updates
A scientific hub to keep you informed about our latest research and company updates.
Press Release: InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications
Press release | Leiden, 25 January 2021 InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications Commercial availability of the in vitro glioblastoma Minibrain organoid platform paves the way for personalized...
A day in the life of InnoSer senior research associate Sarah Aerts
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
A day in the life of InnoSer Organ-on-Chip product manager Alex Bastiaens
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
InnoSer offers in vivo and in vitro imaging capabilities
InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
InnoSer welcomes Edith Simar as its new Business Development Manager
Starting from September 2020, Edith Simar joined the InnoSer team as a business development manager. Thanks to her earlier work and connections in Belgium, France, and Luxembourg Edith will especially strengthen InnoSer’s relationships with (prospective) French...
Midbrain Organoids Free Webinar With Javier Jarazo
InnoSer is inviting all interested in using midbrain organoids as a platform for Parkinson's disease drug development to its webinar organized in collaboration with OrganoTherapeutics. The presentation outlining the platform characteristics and use will be given by...
info@innoserlaboratories.com